RSS
sexual health
Mylan joins fight to prevent HIV infection through PrEP trial
Global pharmaceutical company, Mylan, is joining in the battle to prevent HIV infection by delivering the world’s biggest pre-exposure prophylaxis (PrEP) implementation trial, which will target an estimated 10,000 high risk people. Read more
Shutterstock.com
Trial of HIV prevention drugs to start in five locations in England
A three-year trial of the pre-exposure prophylaxis (PrEP) for the prevention of HIV infection has been announced by NHS England and will be the largest single study of its type in the world with an estimated 10,000 people expected to be included. Read more
